SLCTR_2018_027

A randomized controlled trial to evaluate the effectiveness of Celecoxib vs placebo as an additional treatment for depression in outpatients of Colombo North Teaching hospital Ragama.

Celecoxib as adjunctive therapy in depression: a double- blind, randomized controlled trial
Faculty of Medicine, University of Kelaniya·Phase 4·Sri Lanka Clinical Trials Registry
Study focus
Disease/Condition
Depression
Study type
Interventional
Sponsor & location
Primary sponsor
Faculty of Medicine, University of Kelaniya
Location
Sri Lanka
Timeline & enrollment
Phase
Phase 4
Start date
N/A
End date
N/A
ICD-10 classifications
Depressive episodeOther depressive episodesRecurrent depressive disorderRecurrent depressive disorder, unspecifiedPost-schizophrenic depression
Data source
Registry
Sri Lanka Clinical Trials Registry
Trial ID
SLCTR_2018_027
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for SLCTR_2018_027 through Pure Global AI's free database. This Phase 4 trial is sponsored by Faculty of Medicine, University of Kelaniya and is currently status unknown. The study focuses on Depression.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Sri Lanka Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.